Methylation of SOCS-1 Gene in Pancreatic Cancer
Author Information
Author(s): Fukushima N, Sato N, Sahin F, Su G H, Hruban R H, Goggins M
Primary Institution: The Johns Hopkins Medical Institutions
Hypothesis
The study investigates the prevalence and significance of SOCS-1 methylation in pancreatic neoplasms.
Conclusion
SOCS-1 is commonly methylated in pancreatic adenocarcinoma, and its loss is moderately associated with increased IL-6-mediated growth.
Supporting Evidence
- 31.6% of pancreatic cancer cell lines showed SOCS-1 methylation.
- 21.7% of resected primary pancreatic ductal adenocarcinomas had SOCS-1 methylation.
- 5.9% of intraductal papillary mucinous neoplasms (IPMNs) showed SOCS-1 methylation.
Takeaway
The study found that a gene called SOCS-1, which usually helps control cell growth, is often turned off in pancreatic cancer, which might help the cancer grow faster.
Methodology
The study used methylation-specific PCR to analyze SOCS-1 methylation in various pancreatic neoplasms and cell lines.
Limitations
The study primarily focuses on a subset of pancreatic adenocarcinomas, limiting the generalizability of the findings.
Participant Demographics
Patients included 33 men and 27 women with pancreatic ductal adenocarcinoma, mean age 65.6 years.
Statistical Information
P-Value
0.015
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website